Mrna Manufacturing Facility In Kenya

MODERNA United States has Released a tender for Mrna Manufacturing Facility In Kenya in Pharmaceuticals. The tender was released on Jan 01, 1970.

Country - United States

Summary - Mrna Manufacturing Facility In Kenya

Deadline - login to view

MT reference number - 10468780

Product classification -

Organization Details:

  Address - United States

  Contact details - 565656565

  Tender notice no. - 76454545

  MT Ref Id - 10468780

  Document Type - Tender Notices

Notice Details and Documents:

Description - Scope : Moderna has signed a memorandum of understanding (MoU) with the Government of the Republic of Kenya to build a messenger ribonucleic acid (mRNA) manufacturing facility in the country.The MoU was signed by the company with assistance from the US Government.Moderna is establishing this facility in Africa to manufacture up to 500 million vaccines doses per year. The company plans to invest up to $500m in this new plant, which is intended to carry out drug substance production for Kenya.The facility might be extended to incorporate fill/finish as well as packaging expertise at the site. The mRNA pipeline of the company in its preventive vaccines modality comprises 28 vaccine programmes i

Mt Ref Id - 10468780

Deadline - Dec 31, 2023

Share

View more tenders for

United States Tenders